Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases [Turk Kardiyol Dern Ars]
Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases
Ahmet Güner, Emrah Bayam, Semih Kalkan, Sabahattin Gündüz, Mehmet ÖzkanDepartment of Cardiology, Kartal Koşuyolu High Speciality Training and Research Hospital, İstanbul, Turkey
Pregnancy is associated with an increased risk of valve thrombosis in patients with a mechanical prosthetic heart valve. The administration of low molecular weight heparin (LMWH) with regular anti-factor Xa assessment is a recommended treatment modality for these patients. Presently described are 3 cases of therapy with LMWH during pregnancy. Despite frequent anti-factor Xa monitoring, not surprisingly, all of them developed prosthetic valve thrombosis.
How to cite this article Ahmet Güner, Emrah Bayam, Semih Kalkan, Sabahattin Gündüz, Mehmet Özkan. Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases. Turk Kardiyol Dern Ars. 2019; 47(1): 63-68
Corresponding Author: Ahmet Güner, Türkiye Manuscript Language: English